Intermediate Uveitis

This type of uveitis affects the middle part of the eye. It involves the pars plana and ciliary body. This type can sometimes be chronic, meaning it lasts a long time.

Condition

What people with Intermediate Uveitis report

Every report comes from a Lived member, sent anonymously.

Have you had Eye Injections for Intermediate Uveitis?

NameHow it went

About Intermediate Uveitis

What It Is

Intermediate uveitis is inflammation inside the eye that centers on the vitreous, the clear gel that fills the eye, and on the nearby ciliary body and outer edge of the retina. Inflammatory cells drift into the gel, and people usually notice painless floaters (dark spots or threads moving across their vision) or blurring. Unlike the more familiar front-of-the-eye uveitis, it rarely causes redness, pain or light sensitivity, so it can go unnoticed for a long time, especially in children. It tends to start gradually, often affects both eyes to different degrees, and frequently lasts for years with flares and quieter periods. When no underlying cause is found and the eye shows characteristic clumps of inflammatory cells (called snowballs and snowbanks), the condition is called pars planitis, the most common form. Intermediate uveitis is uncommon, but it matters because long-running inflammation can damage the parts of the eye needed for clear vision.

Causes & Risk Factors

Most intermediate uveitis appears to come from the immune system attacking the eye's own tissue, and in many people no trigger is ever identified. Some cases are linked to a condition elsewhere in the body. Multiple sclerosis (MS) and sarcoidosis, an inflammatory disease that often affects the lungs, are the best-known associations. Infections such as syphilis, tuberculosis and Lyme disease can also produce this pattern, which is why they are looked for before treatment starts. It can begin at any age. Pars planitis is especially common in children and young adults, and an inherited immune makeup appears to raise the likelihood in some people. Having intermediate uveitis, particularly with inflamed retinal veins, is associated with a higher chance of later developing MS, though most people do not.

How It's Diagnosed

An eye doctor, often a uveitis or retina specialist, makes the diagnosis by examining the back of the eye through dilated pupils. They grade how cloudy the vitreous gel looks, search the far edge of the retina for snowballs and snowbanks, and check whether inflammation is mainly in the middle of the eye rather than the front or back. Optical coherence tomography (OCT), a quick scan that photographs the layers of the retina, checks for macular edema: fluid swelling in the macula, the small central area responsible for sharp reading and face vision. A dye test called fluorescein angiography can show leaking or inflamed blood vessels. Because the same eye findings can come from several causes, blood tests and imaging look for syphilis, tuberculosis, Lyme disease and sarcoidosis (often with a chest X-ray or CT scan). A brain MRI may be advised when MS is a possibility. In older adults, a lymphoma that starts in the eye can mimic uveitis, so a specialist may recommend a sample of the vitreous gel if the picture is unusual or the inflammation does not respond to treatment.

Treatment Options

Not everyone needs treatment right away. People with mild inflammation, good vision and no macular swelling are sometimes monitored closely instead. Treatment is started when vision is reduced, the gel is heavily clouded, or macular edema or other complications develop, and the goal is to quiet the inflammation completely. Any infection must be ruled out first, because steroids and immune-suppressing drugs can make an infection worse; infectious causes are treated with antibiotics or other anti-infective medicines. Corticosteroids (steroids) are the usual first step. They can be injected beside or into the eye, which suits inflammation affecting one eye, or taken as pills such as prednisone when both eyes are affected or the disease is severe. A slow-release dexamethasone implant (Ozurdex) can be placed in the eye to release steroid gradually over time. The main trade-off of steroids in the eye is a higher risk of cataract and raised eye pressure, which can lead to glaucoma, so pressure checks are a routine part of care. When inflammation keeps returning, needs long courses of steroid pills or causes steroid side effects, doctors add steroid-sparing medicines that calm the immune system, such as methotrexate. Adalimumab (Humira), an injectable biologic that blocks a protein called tumor necrosis factor (TNF), is approved for this type of uveitis in adults and children 2 and older. These medicines lower the body's defense against infection and need regular blood tests. Because TNF blockers can trigger or worsen MS and similar nerve conditions, doctors weigh them carefully in anyone with MS or neurological symptoms. Surgery to remove the inflamed vitreous gel (vitrectomy) or laser treatment to the retina's edge may help when medicines are not enough or when bleeding, scar tissue or retinal pulling develops. Cataracts can be removed once inflammation has been quiet for a period, often around three months.

What to Expect

Intermediate uveitis is usually a long-term condition with periods of activity and calm, and only a minority of people have a single episode that settles. Many people keep good vision for years, especially when inflammation is controlled early, but complications are common: around half of people develop at least one during the course of the disease. Macular edema is the main cause of blurred vision, and cataract, glaucoma, scar tissue on the retina and, less often, retinal detachment can also occur. Follow-up is frequent while inflammation is active, sometimes every few weeks, and stretches to every three to six months once things are stable. Visits usually involve eye pressure checks and OCT scans, along with blood tests if you take immune-suppressing medicine. Children may not notice or report changes in vision, so regular examinations are especially important. Blurring in one eye during early childhood can also lead to amblyopia (lazy eye), where the brain stops relying on that eye, so keeping inflammation and its complications under control matters for a child's long-term sight.

When to Seek Help

Book an eye examination if you develop new floaters or gradual blurring that do not settle, particularly if you have MS, sarcoidosis. If you already have intermediate uveitis, contact your eye doctor promptly about a clear increase in floaters, or new or worsening blurring, which can signal a flare or macular swelling. If an eye becomes red, painful, light-sensitive or loses vision in the days after an injection or implant, seek same-day care from an ophthalmologist, because infection inside the eye can follow an injection. A sudden shower of new floaters with flashes of light, or a shadow or curtain moving across part of your vision, can mean a retinal detachment: go to your eye doctor or an emergency room right away.

Questions to Ask Your Doctor

  1. 1.Is my uveitis linked to an infection or another condition such as multiple sclerosis or sarcoidosis, and what tests will tell us?
  2. 2.Does the inflammation need treatment now, or is it mild enough to monitor, and what would change that decision?
  3. 3.How do injections or an implant in the eye compare with steroid pills or immune-suppressing medicine for my situation?
  4. 4.How will we watch for macular swelling, raised eye pressure and cataract, and how often should I be examined?
  5. 5.If my child has this condition, what can we do to protect their vision and prevent lazy eye?

Last reviewed • Oct 2026

Educational content, not medical advice.